CLOMIPRAMINE Safety Questions, CLOMIPRAMINE Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about CLOMIPRAMINE. Our extensive database of CLOMIPRAMINE adverse events and CLOMIPRAMINE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about CLOMIPRAMINE
CLOMIPRAMINE Safety Reports
Total CLOMIPRAMINE reports: 12.CLOMIPRAMINE FDA safety alerts: No.
Reported deaths: 3 Reported hospitalizations: 7.
Take CLOMIPRAMINE Side Effects Survey or Share Your CLOMIPRAMINE Story. Read More Here.
Health Professional from BELGIUM reported CLOMIPRAMINE problem on Dec 19, 2006. Female patient, 35 years of age, was treated with CLOMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: anticholinergic syndrome, bezoar, blood pressure decreased, electrocardiogram qrs complex prolonged, grand mal convulsion, hypotension, intentional overdose, metabolic acidosis, oesophageal obstruction. CLOMIPRAMINE dosage: unknown. During the same period patient was treated with MIRTAZAPINE. Patient was hospitalized. Patient recovered.
CLOMIPRAMINE problem was reported by a Health Professional from BELGIUM on Dec 19, 2006. Female patient, 35 years of age, was treated with CLOMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: anticholinergic syndrome, bezoar, electrocardiogram qrs complex prolonged, grand mal convulsion, hypotension, intentional overdose, metabolic acidosis, procedural complication, respiratory acidosis. CLOMIPRAMINE dosage: unknown. During the same period patient was treated with MIRTAZAPINE. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported CLOMIPRAMINE problem on Jan 05, 2007. Female patient, 40 years of age, was treated with CLOMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: alcohol poisoning, dry skin, electrocardiogram qrs complex prolonged, grand mal convulsion, metabolic acidosis, mydriasis, pain. CLOMIPRAMINE dosage: 50MG/DAY, ORAL; SEE IMAGE. During the same period patient was treated with FLUOXETINE, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.
CLOMIPRAMINE problem was reported by a Health Professional from UNITED KINGDOM on Jan 08, 2007. Female patient, 40 years of age, was treated with CLOMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: alcohol poisoning, confusional state, dry skin, electrocardiogram qrs complex prolonged, grand mal convulsion, intentional overdose, metabolic acidosis, mydriasis. CLOMIPRAMINE dosage: 50 MG, ORAL. During the same period patient was treated with FLUOXETINE, LORAZEPAM, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported CLOMIPRAMINE problem on Feb 01, 2007. Female patient was diagnosed with depression and was treated with CLOMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: autism. CLOMIPRAMINE dosage: unknown. Patient recovered.
CLOMIPRAMINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 10, 2007. Male patient, weighting 170.0 lb, was treated with CLOMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: anaemia, diabetes mellitus, diabetic ketoacidosis, infection, pneumonia. CLOMIPRAMINE dosage: unknown. During the same period patient was treated with SERTRALINE, METOPROLOL SUCCINATE, ZYPREXA. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported CLOMIPRAMINE problem on May 18, 2007. Female patient, 62 years of age, weighting 121.3 lb, was diagnosed with obsessive-compulsive disorder and was treated with CLOMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, hyponatraemia, leukopenia, neutrophil count decreased, red blood cell count decreased. CLOMIPRAMINE dosage: 75 MG BID PO. Patient was hospitalized. Patient recovered.
CLOMIPRAMINE problem was reported by a Health Professional from UNITED KINGDOM on Aug 15, 2006. Male patient was diagnosed with depression and was treated with CLOMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction, multi-organ failure. CLOMIPRAMINE dosage: unknown. During the same period patient was treated with QUETIAPINE, ARTHROTEC, LANSOPRAZOLE, MEBEVERINE, ZOLPIDEM TARTRATE. Patient died.
Physician from UNITED STATES reported CLOMIPRAMINE problem on Oct 03, 2006. Male patient was diagnosed with obsessive-compulsive disorder, panic attack and was treated with CLOMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, hyperhidrosis, insomnia. CLOMIPRAMINE dosage: 50 MG BID ORAL. During the same period patient was treated with XANAX, WELLBUTRIN, RITALIN. Patient recovered.
CLOMIPRAMINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 10, 2006. Male patient was diagnosed with depression and was treated with CLOMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction, multi-organ failure, post procedural complication. CLOMIPRAMINE dosage: unknown. During the same period patient was treated with QUETIAPINE, ARTHROTEC, LANSOPRAZOLE, MEBEVERINE, ZOLPIDEM TARTRATE. Patient died.
Health Professional from TURKEY reported CLOMIPRAMINE problem on July 19, 2007. Male patient, 28 years of age, was diagnosed with overdose and was treated with CLOMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: glasgow coma scale abnormal, intubation, overdose, therapeutic agent toxicity. CLOMIPRAMINE dosage: 750 MG. During the same period patient was treated with MAPROTILINE HYDROCHLORIDE, OXCARBAZEPINE, VENLAFAXINE, CITALOPRAM HYDROBROMIDE, DIAZEPAM. Patient was hospitalized. Patient recovered.
CLOMIPRAMINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 10, 2007. Male patient, 51 years of age, was diagnosed with schizoaffective disorder and was treated with CLOMIPRAMINE. After drug was administered, patient experienced the following problems/side effects: constipation, respiratory failure. CLOMIPRAMINE dosage: 125 MG, ORAL. During the same period patient was treated with CLOZAPINE. Patient died.